These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 10100267)
1. Liposomal anthracyclines for brain tumors. Mantadakis E; Kamen B Pediatr Hematol Oncol; 1999; 16(2):89-91. PubMed ID: 10100267 [No Abstract] [Full Text] [Related]
2. Liposomal anthracyclines. Gabizon AA Hematol Oncol Clin North Am; 1994 Apr; 8(2):431-50. PubMed ID: 8040147 [TBL] [Abstract][Full Text] [Related]
3. Second-line chemotherapy with the association of liposomal daunorubicin, carboplatin and etoposide in children with recurrent malignant brain tumors. Fiorillo A; Maggi G; Greco N; Migliorati R; D'Amico A; De Caro MD; Sabbatino MS; Buffardi F J Neurooncol; 2004 Jan; 66(1-2):179-85. PubMed ID: 15015784 [TBL] [Abstract][Full Text] [Related]
4. Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy. Siegal T; Horowitz A; Gabizon A J Neurosurg; 1995 Dec; 83(6):1029-37. PubMed ID: 7490617 [TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma. Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423 [TBL] [Abstract][Full Text] [Related]
6. Liposomal daunorubicin (DaunoXome) in children with recurrent or progressive brain tumors. Lippens RJ Pediatr Hematol Oncol; 1999; 16(2):131-9. PubMed ID: 10100273 [TBL] [Abstract][Full Text] [Related]
7. Intracellular drug delivery by sulfatide-mediated liposomes to gliomas. Shao K; Hou Q; Duan W; Go ML; Wong KP; Li QT J Control Release; 2006 Oct; 115(2):150-7. PubMed ID: 16963144 [TBL] [Abstract][Full Text] [Related]
8. Safety and potential effectiveness of daunorubicin-containing liposomes in patients with advanced recurrent malignant CNS tumors. Boiardi A; Pozzi A; Salmaggi A; Eoli M; Zucchetti M; Silvani A Cancer Chemother Pharmacol; 1999; 43(2):178-9. PubMed ID: 9923826 [No Abstract] [Full Text] [Related]
9. Established and emerging roles of liposomal anthracyclines in oncology. Introduction. Henderson CI Semin Oncol; 2004 Dec; 31(6 Suppl 13):1-4. PubMed ID: 15729770 [No Abstract] [Full Text] [Related]
10. [Liposomal forms of cytostatics in oncology]. Krasnopol'skiĭ IuM; Dranov AL; Stepanov AE; Shvets VI Vestn Ross Akad Med Nauk; 1998; (5):35-40. PubMed ID: 9662995 [TBL] [Abstract][Full Text] [Related]
11. Development of liposomal anthracyclines: from basics to clinical applications. Gabizon A; Goren D; Cohen R; Barenholz Y J Control Release; 1998 Apr; 53(1-3):275-9. PubMed ID: 9741935 [TBL] [Abstract][Full Text] [Related]
12. The liposomal formulation of doxorubicin. Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375 [TBL] [Abstract][Full Text] [Related]